Brainstorm Cell Therapeutics | BCLI - Trade Creditors

Stock Price
0.92
Daily Change
0.03 3.92%
Monthly
33.08%
Yearly
-33.94%
Q1 Forecast
0.82

Brainstorm Cell Therapeutics reported $6.42M in Trade Creditors for its fiscal quarter ending in September of 2025.





Trade Creditors Change Date
Alterity Therapeutics Limited AUD 1.27M 1.81M Dec/2024
Biogen USD 432M 18.9M Dec/2025
Brainstorm Cell Therapeutics USD 6.42M 423K Sep/2025
Cipla INR 30.35B 1.98B Sep/2025
Clal Biotechnology ILS 21.05M 1.62M Dec/2021
Compugen USD 2.35M 6.77M Dec/2025
CSL USD 3.17B 290M Dec/2025
Cytokinetics USD 105.62M 83.53M Dec/2025
Gilead Sciences USD 808M 226M Sep/2025
Grifols EUR 987.75M 47.87M Dec/2025
Halozyme Therapeutics USD 20.9M 5.54M Dec/2025
Mesoblast USD 33.58M 14.49M Dec/2025